Definitive (Chemo)Radiotherapy for Patients With Esophageal Cancer - 3JECROG R-01

CompletedOBSERVATIONAL
Enrollment

2,762

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

September 30, 2017

Study Completion Date

February 28, 2018

Conditions
Esophagus CancerChemoradiationChemotherapy EffectRadiotherapy Side Effect
Trial Locations (1)

100021

Department of Radiation Oncology, Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing

All Listed Sponsors
collaborator

Hebei Medical University Fourth Hospital

OTHER

collaborator

Fujian Cancer Hospital

OTHER_GOV

collaborator

Anyang Tumor Hospital

OTHER

collaborator

The First Affiliated Hospital with Nanjing Medical University

OTHER

collaborator

Affiliated Hospital of Hebei University

OTHER

collaborator

Tianjin Medical University Cancer Institute and Hospital

OTHER

collaborator

Beijing Hospital

OTHER_GOV

collaborator

Tengzhou Central People's Hospital

OTHER_GOV

collaborator

PLA Army General Hospital

UNKNOWN

lead

Chinese Academy of Medical Sciences

OTHER

NCT03298204 - Definitive (Chemo)Radiotherapy for Patients With Esophageal Cancer - 3JECROG R-01 | Biotech Hunter | Biotech Hunter